De Fusco M et al. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet. 2003;33(2):192-6. PMID: 12539047.
Vanmolkot K R et al. Novel mutations in the Na+, K+-ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions. Ann Neurol. 2003;54(3):360-6. PMID: 12953268.
Vanmolkot K R et al. Two de novo mutations in the Na,K-ATPase gene ATP1A2 associated with pure familial hemiplegic migraine. Eur J Hum Genet. 2006;14(5):555-60. PMID: 16538223.
Vanmolkot K R et al. First case of compound heterozygosity in Na,K-ATPase gene ATP1A2 in familial hemiplegic migraine. Eur J Hum Genet. 2007;15(8):884-8. PMID: 17473835.
Pelzer N et al. Familial hemiplegic migraine treated by sodium valproate and lamotrigine. Cephalalgia. 2014;34(9):708-711. PMID: 24443394.
Isaksen T J et al. Insights into the Pathology of the α2-Na(+)/K(+)-ATPase in Neurological Disorders; Lessons from Animal Models. Front Physiol. 2016;7:161. PMID 27199775.
Friedrich T et al. ATP1A2 Mutations in Migraine: Seeing through the Facets of an Ion Pump onto the Neurobiology of Disease. Front Physiol. 2016;7:239. PMID 27445835.
Pelzer N et al. Clinical spectrum of hemiplegic migraine and chances of finding a pathogenic mutation. Neurology. 2018;90(7):e575-e582. PMID: 29343472.